当前位置: X-MOL 学术J. Rheumatol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Dr. Kremer et al reply.
The Journal of Rheumatology ( IF 3.9 ) Pub Date : 2021-10-15 , DOI: 10.3899/jrheum.210992
Joel M Kremer 1 , George Reed 2 , Dimitrios A Pappas 3 , Kevin Kane 2 , Vivi L Feathers 4 , Michael E Weinblatt 4 , Nancy Shadick 4 , Jeffrey Greenberg 5 , Leslie L Harrold 2
Affiliation  

Drs. Pincus, Bergman, and Yazici have raised some concerns about our published article comparing the Clinical Disease Activity Index (CDAI) with simultaneous measures of the Routine Assessment of Patient Index Data 3 (RAPID3).1 We believe our publication has clearly established that the validated CDAI scores provide a fundamentally different evaluation of disease status compared with the RAPID3.

中文翻译:

Kremer 博士等人回复。

博士。Pincus、Bergman 和 Yazici 对我们发表的文章提出了一些担忧,该文章将临床疾病活动指数 (CDAI) 与患者指数数据 3 的常规评估 (RAPID3) 的同时测量值进行了比较。1我们相信,我们的出版物已经清楚地表明,与 RAPID3 相比,经过验证的 CDAI 评分对疾病状态提供了根本不同的评估。
更新日期:2021-10-15
down
wechat
bug